Mutation-Specific and Common Phosphotyrosine Signatures of KRAS G12D and G13D Alleles | Journal of Proteome Research
Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification | PLOS ONE
Genes Co-mutated with KRAS - NCI
Silencing of oncogenic KRAS by mutant-selective small interfering RNA Bjoern Papke1, Salma H. Azam1,2, Anne Y. Feng1, Amanda E.
An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants | bioRxiv
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Sequences of synthetic guide RNA (sgRNA) targeting Kras G12D . | Download Scientific Diagram
sequencing electropherogram of KRAS gene exon 1: (A) g12D mutation; (B)... | Download Scientific Diagram
KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond - ScienceDirect
Sequencing electropherogram of KRAS exon 2. (A) Wild-type. (B) G12D... | Download Scientific Diagram
KRAS G12D Reference Standard, 5%
Addgene: pHAGE-KRAS-G12D Sequences
Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid‑based antisense: A potential new drug candidate for pancreatic cancer
Selective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells | Scientific Reports
Cancers | Free Full-Text | Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
Frontiers | KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
Selective targeting of point-mutated KRAS through artificial microRNAs | PNAS
KRAS mutation analysis (direct sequencing) of codon 12 of exon 2. (A)... | Download Scientific Diagram
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
KRAS G12D can be targeted by potent salt-bridge forming inhibitors | bioRxiv
Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D | PNAS
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
KRAS mutation detection in CD45 depleted blood. The KRAS G12D mutation... | Download Scientific Diagram
